Donor human milk for preterm infants: Current evidence and research directions

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Donor human milk for preterm infants : Current evidence and research directions. / Arslanoglu, Sertac; Corpeleijn, Willemijn; Moro, Guido; Braegger, Christian; Campoy, Cristina; Colomb, Virginie; Decsi, Tamas; Domellöf, Magnus; Fewtrell, Mary; Hojsak, Iva; Mihatsch, Walter; Mølgaard, Christian; Shamir, Raanan; Turck, Dominique; van Goudoever, Johannes; ESPGHAN Committee on Nutrition.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 57, No. 4, 2013, p. 535-542.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Arslanoglu, S, Corpeleijn, W, Moro, G, Braegger, C, Campoy, C, Colomb, V, Decsi, T, Domellöf, M, Fewtrell, M, Hojsak, I, Mihatsch, W, Mølgaard, C, Shamir, R, Turck, D, van Goudoever, J & ESPGHAN Committee on Nutrition 2013, 'Donor human milk for preterm infants: Current evidence and research directions', Journal of Pediatric Gastroenterology and Nutrition, vol. 57, no. 4, pp. 535-542. https://doi.org/10.1097/MPG.0b013e3182a3af0a

APA

Arslanoglu, S., Corpeleijn, W., Moro, G., Braegger, C., Campoy, C., Colomb, V., Decsi, T., Domellöf, M., Fewtrell, M., Hojsak, I., Mihatsch, W., Mølgaard, C., Shamir, R., Turck, D., van Goudoever, J., & ESPGHAN Committee on Nutrition (2013). Donor human milk for preterm infants: Current evidence and research directions. Journal of Pediatric Gastroenterology and Nutrition, 57(4), 535-542. https://doi.org/10.1097/MPG.0b013e3182a3af0a

Vancouver

Arslanoglu S, Corpeleijn W, Moro G, Braegger C, Campoy C, Colomb V et al. Donor human milk for preterm infants: Current evidence and research directions. Journal of Pediatric Gastroenterology and Nutrition. 2013;57(4):535-542. https://doi.org/10.1097/MPG.0b013e3182a3af0a

Author

Arslanoglu, Sertac ; Corpeleijn, Willemijn ; Moro, Guido ; Braegger, Christian ; Campoy, Cristina ; Colomb, Virginie ; Decsi, Tamas ; Domellöf, Magnus ; Fewtrell, Mary ; Hojsak, Iva ; Mihatsch, Walter ; Mølgaard, Christian ; Shamir, Raanan ; Turck, Dominique ; van Goudoever, Johannes ; ESPGHAN Committee on Nutrition. / Donor human milk for preterm infants : Current evidence and research directions. In: Journal of Pediatric Gastroenterology and Nutrition. 2013 ; Vol. 57, No. 4. pp. 535-542.

Bibtex

@article{8dfe77c756064ec2afc48ac168f2c99d,
title = "Donor human milk for preterm infants: Current evidence and research directions",
abstract = "The Committee on Nutrition of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition aims to document the existing evidence of the benefits and common concerns deriving from the use of donor human milk (DHM) in preterm infants. The comment also outlines gaps in knowledge and gives recommendations for practice and suggestions for future research directions. Protection against necrotizing enterocolitis is the major clinical benefit deriving from the use of DHM when compared with formula. Limited data also suggest unfortified DHM to be associated with improved feeding tolerance and with reduced cardiovascular risk factors during adolescence. Presence of a human milk bank (HMB) does not decrease breast-feeding rates at discharge, but decreases the use of formula during the first weeks of life. This commentary emphasizes that fresh own mother's milk (OMM) is the first choice in preterm infant feeding and strong efforts should be made to promote lactation. When OMM is not available, DHM is the recommended alternative. When neither OMM nor DHM is available, preterm formula should be used. DHM should be provided from an established HMB, which follows specific safety guidelines. Storage and processing of human milk reduces some biological components, which may diminish its health benefits. From a nutritional point of view, DHM, like HM, does not meet the requirements of preterm infants, necessitating a specific fortification regimen to optimize growth. Future research should focus on the improvement of milk processing in HMB, particularly of heat treatment; on the optimization of HM fortification; and on further evaluation of the potential clinical benefits of processed and fortified DHM.",
author = "Sertac Arslanoglu and Willemijn Corpeleijn and Guido Moro and Christian Braegger and Cristina Campoy and Virginie Colomb and Tamas Decsi and Magnus Domell{\"o}f and Mary Fewtrell and Iva Hojsak and Walter Mihatsch and Christian M{\o}lgaard and Raanan Shamir and Dominique Turck and {van Goudoever}, Johannes and {ESPGHAN Committee on Nutrition}",
note = "CURIS 2013 NEXS 250",
year = "2013",
doi = "10.1097/MPG.0b013e3182a3af0a",
language = "English",
volume = "57",
pages = "535--542",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams & Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - Donor human milk for preterm infants

T2 - Current evidence and research directions

AU - Arslanoglu, Sertac

AU - Corpeleijn, Willemijn

AU - Moro, Guido

AU - Braegger, Christian

AU - Campoy, Cristina

AU - Colomb, Virginie

AU - Decsi, Tamas

AU - Domellöf, Magnus

AU - Fewtrell, Mary

AU - Hojsak, Iva

AU - Mihatsch, Walter

AU - Mølgaard, Christian

AU - Shamir, Raanan

AU - Turck, Dominique

AU - van Goudoever, Johannes

AU - ESPGHAN Committee on Nutrition

N1 - CURIS 2013 NEXS 250

PY - 2013

Y1 - 2013

N2 - The Committee on Nutrition of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition aims to document the existing evidence of the benefits and common concerns deriving from the use of donor human milk (DHM) in preterm infants. The comment also outlines gaps in knowledge and gives recommendations for practice and suggestions for future research directions. Protection against necrotizing enterocolitis is the major clinical benefit deriving from the use of DHM when compared with formula. Limited data also suggest unfortified DHM to be associated with improved feeding tolerance and with reduced cardiovascular risk factors during adolescence. Presence of a human milk bank (HMB) does not decrease breast-feeding rates at discharge, but decreases the use of formula during the first weeks of life. This commentary emphasizes that fresh own mother's milk (OMM) is the first choice in preterm infant feeding and strong efforts should be made to promote lactation. When OMM is not available, DHM is the recommended alternative. When neither OMM nor DHM is available, preterm formula should be used. DHM should be provided from an established HMB, which follows specific safety guidelines. Storage and processing of human milk reduces some biological components, which may diminish its health benefits. From a nutritional point of view, DHM, like HM, does not meet the requirements of preterm infants, necessitating a specific fortification regimen to optimize growth. Future research should focus on the improvement of milk processing in HMB, particularly of heat treatment; on the optimization of HM fortification; and on further evaluation of the potential clinical benefits of processed and fortified DHM.

AB - The Committee on Nutrition of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition aims to document the existing evidence of the benefits and common concerns deriving from the use of donor human milk (DHM) in preterm infants. The comment also outlines gaps in knowledge and gives recommendations for practice and suggestions for future research directions. Protection against necrotizing enterocolitis is the major clinical benefit deriving from the use of DHM when compared with formula. Limited data also suggest unfortified DHM to be associated with improved feeding tolerance and with reduced cardiovascular risk factors during adolescence. Presence of a human milk bank (HMB) does not decrease breast-feeding rates at discharge, but decreases the use of formula during the first weeks of life. This commentary emphasizes that fresh own mother's milk (OMM) is the first choice in preterm infant feeding and strong efforts should be made to promote lactation. When OMM is not available, DHM is the recommended alternative. When neither OMM nor DHM is available, preterm formula should be used. DHM should be provided from an established HMB, which follows specific safety guidelines. Storage and processing of human milk reduces some biological components, which may diminish its health benefits. From a nutritional point of view, DHM, like HM, does not meet the requirements of preterm infants, necessitating a specific fortification regimen to optimize growth. Future research should focus on the improvement of milk processing in HMB, particularly of heat treatment; on the optimization of HM fortification; and on further evaluation of the potential clinical benefits of processed and fortified DHM.

U2 - 10.1097/MPG.0b013e3182a3af0a

DO - 10.1097/MPG.0b013e3182a3af0a

M3 - Journal article

C2 - 24084373

VL - 57

SP - 535

EP - 542

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 4

ER -

ID: 53996282